SKWD vs WRB: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

WRB is the larger of the two ($29.46B market cap): the incumbent the market prices for continued execution (16.35x forward earnings, beta 0.22). SKWD is the smaller challenger ($2.91B), cheaper on forward earnings (11.68x): more room to run, but more to prove. On the numbers, SKWD leads on both counts: faster expected revenue growth (14% vs 3%) and a lower forward P/E (11.68x vs 16.35x). The case for WRB rests on its own driver (Specialty and E&S underwriting discipline): if you believe in that, WRB fits; if you believe in what the numbers show today, SKWD does.

SKWD vs WRB: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricSKWDWRBWhat it tells you
Market cap$2.91B$29.46BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E11.6816.35Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E15.2416.76Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.310.22Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range99% of range98% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book2.283.21How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: SKWD is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how SKWD and WRB affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. SKWD and WRB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined SKWD and WRB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Skyward Specialty Insurance (SKWD) do?

Skyward writes commercial property and casualty insurance in niches most carriers do not staff for. The US business is organised into nine underwriting divisions, each with dedicated leadership: Accident & Health, Captives, Credit & Surety, Energy Solutions, Global Agriculture, Global Property, Professional Lines, Specialty Programs and Transactional E&S. Second-quarter 2026 gross written premiums from those divisions came to ~$667.9M, up 14.1% year over year, with Global Agriculture nearly doubling to ~$111.9M and Accident & Health up 57.8% to ~$95.5M, while Captives, Energy Solutions and Global Property each contracted by mid-teens percentages. Management calls the approach "Rule Our Niche", and the intended consequence is that close to half the book sits in lines that do not track the property catastrophe cycle. On January 1, 2026 the company closed a ~$559.1M purchase of Apollo Group Holdings, paid for with ~$371.1M of cash and 3,679,332 Skyward shares valued at $51.11 each. Apollo underwrites through Syndicates 1969 and 1971 with its own capital and provides managing agency services to nine Lloyd's syndicates in total, which hands Skyward a fee stream on premium it does not carry: ~$318.1M of fee-generating gross written premium in the quarter.

Full SKWD guide

What does W. R. Berkley (WRB) do?

W.R. Berkley Corporation is one of the larger commercial property and casualty insurers in the United States, organized into two reporting segments: an Insurance segment that writes commercial lines, excess and surplus (E&S) coverage, and specialty risks through dozens of separately branded operating units, and a Reinsurance and Monoline Excess segment that assumes risk on a treaty and facultative basis. The decentralized, niche-by-niche structure lets each unit price complex or hard-to-place risks that standard carriers avoid, which is where the company earns much of its underwriting margin.

Full WRB guide

SKWD vs WRB: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • SKWD drivers: Apollo turns an underwriter into a fee earner as well; Nine divisions that grow and shrink on their own schedules.
  • WRB drivers: Specialty and E&S underwriting discipline; Rising investment income on the float.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The largest exposure is reserve adequacy. For WRB, property and casualty insurance is cyclical, and commercial pricing has been softening after several strong years, which could compress future margins if rate increases no longer outpace claims inflation.

SKWD or WRB: which should you pick?

If the story you believe is SKWD's (Apollo turns an underwriter into a fee earner as well), SKWD is the more direct way to own it; if it is WRB's (Specialty and E&S underwriting discipline), WRB is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the SKWD and WRB guides.

SKWD vs WRB: the full fundamentals

SKWD. A screener's ~1.6x price-to-sales figure carries almost no signal for SKWD, because insurance revenue is premium the company has already promised to pay claims against. The multiples that carry information are price to book, ~2.3x in November 2026, and forward earnings, ~11.7x, which sit below the levels the market has awarded the fastest-growing US excess and surplus underwriters and above carriers whose returns hover near their cost of capital. On tangible book the multiple is closer to 3.4x, since ~$471.2M of the equity base is goodwill and intangibles from Apollo.

WRB. At $79.36 on November 20, 2026, WRB trades at about 17x trailing and 16x forward earnings and roughly 3.2x book value, a premium multiple for a P&C insurer that its high-teens return on equity has so far supported. Q3 2026 operating EPS of $1.17 edged past the ~$1.16 estimate, and Q4 results are expected around January 25, 2027 with consensus near $1.21. The regular yield near 0.5% understates cash returned because Berkley often adds special dividends.

Headline figures (approximate, November 2026): SKWD shows revenue (ttm) ~$1.81B for the twelve months to September 30, 2026, up ~19% year over year in the latest quarter, against ~$1.42B in fiscal 2025, ~$1.15B in 2024 and ~$886M in 2023. Quarterly revenue ran ~$475.9M, ~$489.5M and ~$455.3M across the first three quarters of 2026, with Apollo included from January 1., margins Operating margin ~15.7% and net profit margin ~10.6% on a trailing basis. For an insurer the combined ratio carries more information: 89.9% in the third quarter of 2026 (61.7% loss, 28.2% expense), 89.5% in the second, 89.3% for full-year 2025 and 92.3% for 2024., net income and eps Trailing net income ~$191.8M and EPS ~$4.30. Third-quarter 2026 net income ~$49.8M with EPS of ~$1.28 against a ~$1.22 consensus and ~$1.05 a year earlier; nine-month net income ~$148.6M. Full-year 2025 net income was ~$170.0M., p/e ~15.2x trailing and ~11.7x forward, against analyst EPS estimates of ~$5.10 for 2026 and ~$5.61 for 2027.; WRB shows market cap ~$29.5B at $79.36 (Nov 20, 2026), revenue (ttm) ~$14.9B; Q3 2026 ~$3.21B, net premiums written (q3 2026) ~$3.27B, up ~1.3% YoY, combined ratio (q3 2026) ~90.8%; ~88.1% current accident year ex-cat.

The bottom line: SKWD vs WRB

SKWD and WRB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined SKWD and WRB exposure against your real portfolio. It is not an investment adviser.

Wondering how SKWD or WRB fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Skyward Specialty Insurance

Ask Walnut's AI anything about SKWD and see how it fits what you own.

FAQ

What is the difference between SKWD and WRB?

+

Skyward writes commercial property and casualty insurance in niches most carriers do not staff for. W.R. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is SKWD or WRB the better stock?

+

Neither is universally better. WRB is the larger incumbent; SKWD is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, SKWD or WRB?

+

On forward P/E (as of November 2026), SKWD trades at 11.68x and WRB at 16.35x, so SKWD is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both SKWD and WRB?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of SKWD vs WRB?

+

SKWD: The largest exposure is reserve adequacy. Net loss reserves of ~$1,908.1M exceed shareholders' equity of ~$1,267.5M by half again, so a 5% deficiency across the book would consume roughly 7% of book value before tax. Growth compounds that: Global Agriculture premium nearly doubled year over year and Accident & Health rose 57.8%, and immature accident years in fast-growing lines are where estimation error tends to appear two or three years later. A second, less discussed exposure is credit. Reinsurance recoverables of ~$1,411.6M are larger than the entire equity base, and Skyward remains liable to policyholders if a reinsurer fails to pay. The company has also been retaining more risk itself, with net retention on a written basis rising to 65.6% in the second quarter of 2026 from 58.0% a year earlier, which raises the loss volatility that reaches the income statement. Apollo brings its own set. Goodwill and intangibles of ~$471.2M now equal ~37% of equity, including $200M of indefinite-lived syndicate capacity that is tested for impairment rather than amortised, and the 10-Q states that the assessment of internal control over financial reporting excludes Apollo while integration continues. The Lloyd's segment ran a 97.6% combined ratio in the quarter with 5.4 points of catastrophe loss attributed primarily to the conflict in the Middle East, a reminder that the acquired book carries political and war exposure the US divisions largely do not. Pricing is the background condition: management's own 2026 guidance assumes a 90.5% to 91.5% combined ratio, above the 89.5% delivered in the first half, which implies an expected second-half deterioration. Alternative and strategic investments have been a persistent drag, costing ~$8.1M in the first half of 2026 after ~$11.5M in 2025. Chief Financial Officer Mark Haushill is retiring effective March 31, 2027. Top-line growth is also less steady than the earnings beats suggest: third-quarter revenue of ~$455.3M was ~10% below consensus and below the ~$489.5M of the second quarter, and Zacks has questioned whether profit growth can continue while net premiums decline. Finally, the share price now carries more expectation than in the summer: at ~$65.44 on November 20, 2026 the stock sits at the top of its ~$40.60 to ~$65.88 52-week range after a ~34.6% gain this year, so a reserve surprise or a further revenue shortfall would land on a fuller multiple. WRB: Property and casualty insurance is cyclical, and commercial pricing has been softening after several strong years, which could compress future margins if rate increases no longer outpace claims inflation. Consensus already points to slightly lower EPS in 2027, net premiums written grew only about 1.3% in Q3 2026, and return on equity has come down from 24% to about 18% over a year. Reserve adequacy is a persistent risk: if past claims prove more costly than booked, prior-year reserve charges hit earnings. Catastrophe exposure from hurricanes, wildfires, and severe convective storms can spike losses in any quarter. Investment income depends on interest rates, so a sharp decline in yields would slow that engine, and credit or equity losses in the portfolio would flow through book value. Finally, after a ~16% three-month rally the shares trade just above 3x book and above the average analyst target of about $70 (17 analysts, consensus hold), so any slip in the combined ratio could pressure the multiple.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell SKWD or WRB; figures are approximate and dated (as of November 2026). Verify current data before investing.